AKBA

AKEBIA THERAPEUTICS, INC.

AKBA · CIK 1517022 · Annual (10-K) · Last 8 years

Financial Trends

Revenue$236M
20182025
Net Income−$5M
20182025
Operating CF$68M
20182025
Free Cash Flow$68M
20182025

Income Statement

MetricFY 2025↕FY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕FY 2018↕
Revenue$0.2B$0.2B$0.2B$0.3B$0.2B$0.3B$0.3B$0.2B
Cost of Revenue$0.0B$0.1B$0.1B$0.1B$0.2B$0.1B$0.0B$0.0B
Gross Profit————————
R&D Expense$0.1B$0.0B$0.1B$0.1B$0.1B$0.2B$0.3B$0.3B
SG&A Expense$0.1B$0.1B$0.1B$0.1B$0.2B$0.2B$0.1B$0.1B
Operating Income$0.0B$-0.1B$-0.0B$-0.1B$-0.3B$-0.1B$-0.1B$-0.1B
Net Income$-0.0B$-0.1B$-0.1B$-0.1B$-0.3B$-0.1B$-0.1B$-0.1B
EPS (Basic)$-0.02$-0.33$-0.28$-0.51$-1.70——$0.33
EPS (Diluted)$-0.02$-0.33$-0.28$-0.51$-1.70——$0.31

Balance Sheet

MetricFY 2025↕FY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕FY 2018↕
Total Assets$0.4B$0.2B$0.2B$0.4B$0.5B$0.6B$0.8B$1.0B
Current Assets$0.3B$0.1B$0.1B$0.2B$0.3B$0.4B$0.3B$0.5B
Cash & Equivalents$0.2B$0.1B$0.0B$0.1B$0.1B$0.2B$0.1B$0.1B
Total Liabilities$0.3B$0.3B$0.3B$0.3B$0.4B$0.4B$0.4B$0.4B
Current Liabilities$0.2B$0.1B$0.1B$0.1B$0.3B$0.2B$0.2B$0.3B
Stockholders' Equity$0.0B$-0.0B$-0.0B$0.0B$0.1B$0.2B$0.4B$0.6B

Cash Flow Statement

MetricFY 2025↕FY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕FY 2018↕
Operating Cash Flow$0.1B$-0.0B$-0.0B$-0.1B$-0.3B$-0.1B$-0.3B$-0.1B
Investing Cash Flow$-0.0B$-0.0B$0.0B$-0.0B$0.0B$-0.0B$0.2B$0.0B
Capital Expenditures$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B
Financing Cash Flow$0.1B$0.0B$-0.0B$0.0B$0.1B$0.2B$0.1B$0.1B
← Companies